The experiments that will be described demonstrate that myeloid leukemia of a mammal (mouse) is transmissible and is a neoplasm that affects the precursors of granular leukocytes, the same cells producing myeloid leukemia and myeloma. Snijders (1) has shown that lymphatic leukemia of guinea pigs is transmissible, and independent studies of subsequent workers found this to be true for lymphatic leukemia of mice (2-5). The isolation of the strain of myeloid leukemia here described has made possible a study of the pathogenesis of myeloid leukemia and its relation to myeloma, and has made available a constant source of malignant myeloid cells.
The experiments that will be described demonstrate that myeloid leukemia of a mammal (mouse) is transmissible and is a neoplasm that affects the precursors of granular leukocytes, the same cells producing myeloid leukemia and myeloma. Snijders (1) has shown that lymphatic leukemia of guinea pigs is transmissible, and independent studies of subsequent workers found this to be true for lymphatic leukemia of mice (2) (3) (4) (5) . The isolation of the strain of myeloid leukemia here described has made possible a study of the pathogenesis of myeloid leukemia and its relation to myeloma, and has made available a constant source of malignant myeloid cells.
Origin of Strain
Routine examination of our colony revealed a mouse (No. Ar 117) with a greatly enlarged and readily palpable spleen; some of the lymph nodes of this mouse were slightly enlarged. The leukocyte count was 103,000 per c.mm.; most of these white blood cells were myeloid cells but only 9.5 per cent of them were myelocytes with coarse basophile granules that were subsequently identified as the malignant myeloid cells characteristic of this strain (Figs. 1 to 3).
Neutrophile polynuclear leukocytes were 31 per cent, neutrophile myeiocytes and metamyelocytes 20 per cent, eosinophile g~nuloeytes 0.5 per cent, ceils like monocytes 17 per cent, cells like monocytes with basopbile cytoplasm (Fig. 1 ) 11.5 per cent, lymphocytes 10.5 per cent. The great enlargement of the spleen was due to infiltration with myelocytes containing coarse basophfle granules * This investigation has been supported by a Fund for the Study of Leukemia. 423 (Fig. 19) . The pulp was densely packed with these cells and the lymphoid tissue atrophied. The liver was moderately enlarged and its sinusoids were distended with basophile mydocytes (Fig. 17) . The femoral marrow was a dense mass of these cells (Fig. 22) . The structure of the lymph nodes was retained but basophile mydocytes filled their sinuses (Fig. 20) . Wherever found, many of these mydoid cells were in the process of mitotic division. Their abundant, coarse granulation, stained purple to black with Azure II, made them readily recognizable in any location. The n~terlal of study, the technic of inoculation and of irradiation, and the stocks of mice used have been described (5) . All mice used in this study were bred in our laboratory and are members of one of three different stocks named A, R, and S. These stocks have been inbred since 1928, and were split up into a number of families that were derived from brother and sister matings. These f~miHes were designated by adding small letters to the capitals A, R, and S. Members of the different stocks (/I, R, and S) are regarded as being unrelated, members of the same family (e.g., At) as being related.
The medium used in the preparation of cell suspension was either Tyrode or Locke solution. The intravenously injected cell suspension contained from 30,000 to 100,000 leukocytes per c~rnrn, and was injected in amounts of 0.1 cc. Mice that appeared healthy were killed from 80 to 150 days after inoculation.
Three of the four irradiated mice inoculated intravenously were very ill about 2 weeks after inoculation; they had enlarged spleens and numerous basophilc myelocytes in the blood. On postmortem examination all showed diffuse myelosis and material from these mice transmitted the disease to most of the mice inoculated with it. The similarly inoculated, unirradlated, but related mice remained healthy with the exception of one mouse that developed a nodular swelling about I cm. in diameter in the submaxillary region. This was thought to be an abscess and the mouse was killed 49 days after injection; but autopsy showed that it was a growth composed entirely of basophile myelocytes. S~mi|~r nodules were found in the abdominal muscles, diaphragm, and lungs, and there was a diffuse microscopic infiltration of the spleen and liver by basophile myelocytes, but the antemortem blood smear was normal. The six mice successfully inoculated intrasplenically developed small nodules in the subcutaneous tissue at the site of needle puncture, and extensive abdominal myelomatosis. Antemortem invasion of the blood by basophile myelocytes was seen in two of these mice. The spleens and livers appeared to be normal, or showed slight diffuse or nodular inAltrations. The course of the disease was slow in the unirradlated mice and they died from 2 to 3 months after the injection.
The inference was drawn from this experiment that the discase is more readily transmitted to irradiated than to unirradiated mice. In further subpassages irradiated mice wcrc used to propagate this strain of myeloid leukemia and unirradiated mice of the diffcrcnt stocks to test their susceptibility. In order to establish the optimal conditions of transfer and the anatomical changes under the various conditions of inoculations, the route of inoculation was varied, and different tissues were used for injection.
Subsequent work has shown that the discasc is readily transmissible by tissues containing live basophilc myelocytes; but transmission fails when they arc not present. Further attempts to inoculate the spleen directly seemed superfluous, for it was evident that these malignant myeloid cells would grow in the subcutaneous tissue or in the abdominal cavity and form tumors in these sites (Figs. 8, 9 ). Neither the individuality of the host nor the site of inoculation modified the characteristics of these malignant myeloid cells. Table II is a summary of fourteen intravenous passages in irradiated mice and shows that the inoculations were successful in 88.6 per cent of the animals. The inoculations in irradiated mice by routes other than intravenous (Table III) were somewhat less successful (78 per cent). In four of the mice included among the successful inoculations in this table the growth that developed at the site of inoculation regressed. The anatomical changes in relation to the route of injection will be dealt with later.
Nodular growth about the sternum, vertebrae, and kidney, found in the mice of the first passages, suggested the attempts of producing such nodules by injecting a suspension of immature mydoid cells about these tissues. These inoculations resulted in the formation of growths at the site of injection and they were abandoned as soon as it was recognized that similar growth may be readily produced in the subcutaneous tissue and abdominal cavity.
It requires a long period for the malignant myeloid cells to form a grossly detectable growth, when introduced into the subcutaneous tissues; but similar cells produce fatal myeloid leukemia within from 2 to 3 weeks when introduced intravenously. Barely detectable nodules were occasionally found in the subcutaneous tissue 2 months after inoculation with fairly large doses, and it is probable that the incubation period can be prolonged by decreasing the inoculating dose. These data are of interest in relation to the long period of latency of some malignant neoplasms.
Inoculations are less often successful in unirradiated than in irradiated mice and the disease produced is more chronic (Table IV) . Direct offspring of the mouse with the spontaneous disease (No. Ar 117) were not available for inoculation. Forty-one mice that could be traced back to the same parents as No. Ar 117 (Stock Ar) were tested and sixteen (39 per cent) proved susceptible; of forty unrelated mice (Stocks R and S) tested, six (15 per cent) proved susceptible (Table IV) . 
Attempts at Transmission with Material Free from Viable Cells
Four different procedures t h a t served best to demonstrate the existence of viruses capable of transmitting leukosis of chickens were used to determine whether the myeloid leukemia Strain Ar 117 can be Intrssplenic (?) Perirenal Freezing and Thawing.--Tlfis procedure has often been used in studies undertaken to demonstrate cell-free transmission, but it has led to erroneous conclusions, probably because of faulty technic (cJ. 5) . It is essential to seal in a test tube the material to be frozen, to submerge it in a liquid that is chilled to known temperature, and to Since the life is lengthened by decreasing the inoculating dose, it seems probable that many cells were injured by freezing at -5 ° and -10°C., and certainly all cells were destroyed at a temperature of -15°C. There seems to be a critical subzero temperature at which the cells die. Experiment IIIc shows that the unfrozen suspension caused myelosis in all mice injected, even when the dilution was 1/400, and data obtained from subsequent work (Table VI) suggest that the minimal dose producing myelosis is far below this quantity.
Drying of the malignant myeloid cells in vacuo while in the frozen state, as described in previous reports (5) , destroyed the agent concerned with the transmission of myelosis.
Plasma was obtained by spinning heparinized blood at a speed of about 1,000 ~.P.~. during 5 minutes, and recentrifugalizing the plasma at a speed of about 2,000 R.1,.~¢. during 15 minutes.
Glycerination was brought about by adding an equal volume of glycerine (e.1,.) to the cell suspension. The experiment shown in Table V is of limited value because it was terminated by error 80 days after inoculation at a time when the tumors in the control mice were still small.
Relation of Dose to the Success of Inoculations; Observations on the Relation of Myeloma to Diffuse Myelosis
Qualitative experiments in search for a filterable agent, such as those shown in Table V , might depend for their success largely on the concentration of the supposed agent in the initial material. It was desirable to know the relation of the quantity of material injected to the success of inoculation, for another reason. When a cell suspension was used for intravenous inoculation, mice that died soon after inoculation 
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leukemic myelosis. This observation indicated that resistance of the host as suggested by the lengthy course of the disease was the major factor in the development of multiple myelosis. Nevertheless it seemed worth while to determine if smaller doses would produce myeloma, and larger doses diffuse myelosis. The results of intravenous inoculation with decreasing doses are summarized in Table VI .
In the last experiment recorded in Table VI the concentrated cell suspension contained 110,000 leukocytes per c.mm. and the volume injected was 0.1 cc.; the mice injected with dilutions of 1/1,000,000 may therefore be estimated to have each received approximately eleven cells. In the remaining experiments the concentrated cell suspension contained from 30,000 to 100,000 leukocytes per c.mm.
Most mice used in these experiments were rendered susceptible by a preceding irradiation with X-rays. The degree of susceptibility induced by X-rays depends on the dose, and after a period of from I to 3 weeks following irradiation it decreases considerably (cf. 5). Hence if the life of the inoculated mice is lengthened by decreasing the amount of the inoculum, inoculations may become unsuccessful merely because the host is given time to regain the resistance lowered by irradiation.
It is remarkable that life is only slightly prolonged by greatly decreasing the inocu.lum and that the number of successful inoculations does not diminish with a delayed incubation period. The supposition that the disease would fail to develop in resistant irradiated mice unless it appeared within a few weeks because these mice had regained their resistance, previously lowered by irradiation, was contradicted by the results of the experiments. A single large dose of X-rays causes a more profound injury than hitherto suspected, or the resistance of the host is overcome by the multiplication of malignant cells during a transient period of lowered resistance. The former assumption finds support in the observations that the incidence of spontaneous lymphomatosis (6) and myelomatosis (7) is increased by a single large dose of X-rays.
The following experiment (Passage IIIi, Experiment c of Table  VI) shows the relation of the length of life to the type of the disease.
In this experiment, mice of Stock A were inoculated 3 days after irradiation with a splenic cell suspension from a mouse with myeloid leukemia. The exact number of cells injected is unknown; the concentrated cell suspension contained 120,000 white cells per cram., but the material had to be refiltered and an unknown number of the cells were lost during this process. Each mouse received 0.1 cc. of cell suspension. The inoculation was unsuccessful in one mouse that was killed 120 days after inoculation; all other mice died or were killed in extremis within 96 days after inoculation. Length Multiple myelonm
Negative
All mice that died within 50 days showed diffuse myelosis; all that lived for at least 72 days showed the formation of nodules attached to bones and viscera. These masses were composed of immature myeloid cells infiltrating the surrounding tissue. Mitotic figures were numerous among the immature myeloid cells and there was no evidence of inflammation. Hence these nodules may be regarded as tumors (myelomata).
The results of all other experiments shown in Table VI were essentially the same. Tumors appeared in mice that received a small dose, whereas mice injected with a large dose developed diffuse myelosis with no tumor formation.
These experiments suggest that the type of disease is largely determined by the number of malignant myeloid cells entering the circulation. Individual resistance as a minor factor is suggested by a few irregularities in the relation of dose to the time of death. Since the resistance of all mice was very low at the beginning of the experiment, as the result of massive irradiation preceding the inoculation, and then gradually returned, it is questionable whether a reduction of the inoculating dose did more than delay the incubation period. Not until highly susceptible unirradiated mice are available for inoculation can the effect of the dose be accurately determined.
The relation of resistance of the host to the type of disease becomes evident when mice with widely differing resistance, namely irradiated and unirradiated mice, are inoculated with the same dose. The obvious explanation of these observations is that resistant mice destroy m a n y of the inoculated malignant myelocytes and a small number of these ceils multiply and form tumors in sites other than the spleen and liver; in the latter organs they perish.
In one experiment the rSle of resistance in the pathogenesis of myelosis was tested by inoculating mice whose resistance was decreased by varying amounts of X-rays. All mice used in this experiment were approximately 3 months of age and they were members of the same family (At). The result of this experiment was as follows:
Unirradiated.
[ The increase in the number of mice with diffuse myelosis and in the number of successful inoculations suggests that the smallest dose of X-rays that increases susceptibility to transmissible myelosis is approximately 100 r (cf. 5) .
Blood Changes
Since the diagnosis of myelosls of Strain Ar 117 can be made by recognition of one or two malignant cells in the blood smear it seemed superfluous to undertake an elaborate quantitative study of morphological changes in the circulating blood. Two procedures were used to obtain malignant cells as free from other cells as possible: (a) inoculation of mice whose blood-forming tissues were depleted by irradiation; (b) production of tumor by subcutaneous or intraperitoneal inoculation of the neoplastic blood ceils. These procedures showed that the malignant cells of Strain Ar 117 are myelocytes with coarse basophile granules that differ morphologically from nonmalignant immature myeloid cells (Figs. 2, 3, 11 to 16 ).
The size of these cells in fixed smears stained with Wright and Giemsa solutions varies greatly; their diameter is from 6 to 14/~, with an average of about 10~. The nucleus is vesicular or slightly indented or lobed. The cytoplasm is slightly or moderately basophilic and contains coarse granules that fail to stain with eosin and hematoxylin, but stain readily with Azure II. In blood smears there are often seen detached cytoplasmic masses with basophilic granules, as shown in Figs. i and 2. The color of these granules varies somewhat in preparations stained with Romanowsky dyes; it is usually dark purple and sometimes it is reddish or very dark and almost black. They do not give the oxydase reaction with Schultze's indophenyl blue.
It is doubtful whether the mouse possesses basophile granular leukocytes (mast cells), such as are found in man (8), but the common promyelocytes of the mouse have basophile granules somewhat smaller than those of the basophile myelocyte of Strain Ar 117 (Fig. 5) . Tissue mast cells, readily demonstrable in lymph nodes of the mouse stained with eosin-azure according to 1VIaximow, and occasionally seen in smears of lymph node, spleen, or heart blood post mortem, are much larger than myelocytes, their granules are much more abundant and more darkly stained (Fig. 6) . Transitional forms between the tissue mast cells and the granular leukocytes of the bone marrow were never seen.
In view of these considerations the characteristic cell of Strain Ar 117 may be regarded as a pathological (malignant) myelocyte.
The number of these cells in the blood stream of the mouse with the spontaneous disease was small (9.5 per cent). The blood smears of irradiated mice that were inoculated intravenously showed, however, numerous basophile myelocytes and almost no other cells. In mice inoculated subcutaneously or intraperitoneally the blood appeared normal during a period of several months, but often there was terminal leukemia. The blood smears of mice with multiple myeloma were, in most instances, free from basophile myelocytes. Table VII shows some figures that illustrate these observations. Myelosis caused by Strain Ar 117 is associated with severe anemia. In all instances in which subcutaneous inoculation was successful there was a tumor at the site of injection (Figs. 8, 21 ).
These tumors were just palpable from 6 to 12 weeks after inoculation and grew slowly until they reached from 3 to 5 cm. in diameter. The affected mice died from 3 to 5 months after the injection. Large subcutaneous tumors often ulcerated and in a small number of mice they regressed. From the subcutaneous tissue the tumors occasionaUy invaded by continuity the peritoneal and pleura1 cavities. Here they formed diffuse infiltrations or tumor nodules Upon the peritoneal and pleursl surfaces and were associated with milky effusions in large quantity. Smear preparations of this effusion (Fig. 3) showed basophfle myelocytes and a few very large mononuclear ceils which were probably desquamated mesothdial cells, but 
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no microorganisms. Distant foci of metastases were found in mice that died or were killed at an advanced stage of the disease. The smears from the blood of these mice appeared normal or more often in the terminal stage of the illness showed basophile myelocytes. Metastatic infiltrations consisted of multiple white, firm tumors similar to the primary tumors and they were found attached to the bones, for example the rib, mandible, vertebra, bones of the skull and of the extremities, or in muscles and viscera. There was often mild diffuse myelosis of spleen and liver.
After intraperitoneal inoculation there was extensive distention of the abdomen caused by the formation of numerous partly confluent tumors attached to the mesentery, diaphragm, and peritoneum (Fig.  9 ). In the peritoneal cavity there was much milky effusion in which the cells were largely basophile myelocytes (Fig. 3) . Blood invasion and formation of metastatic loci were similar to those observed in mice injected subcutaneously.
After intravenous inoculation the changes were different in mice that died from 2 to 5 weeks after injection, from those in mice that died at a later date, but the time relation is only approximate. The former developed diffuse leukemic myelosis (Fig. 7) ; the latter developed myelomata with or without the diffuse systemic disease (Fig. 10) .
In order to study the early manifestations of the disease, irradiated mice inoculated intravenously were killed 4, 8, 12, and 18 days after inoculation.
As early as 4 days after the inoculation, basophile myelocytes were numerous in the pulp of the spleen. Their number was considerable 8 days after injection and they began to accumulate in the sinusoids of the liver and in the bone marrow. Their number per unit area was greatest in the spleen (Fig. 19) , Mmost as great in the bone marrow (Fig. 22) , and much less in the liver (Fig. 18) . They multiplied in these sites by mitosis. As they increased in the pulp of the spleen the lymphoid follicles became smaller. In some mice mitosis was abundant in the lymphoid tissues, apparently as the result of regeneration following injury caused by X-rays. The malignant myeloid cells showed progressive growth in the sinusoids of the spleen. These became distended with basophile myelocytes and conrained only a few erythrocytes. In the lymph nodes there was slight accumulation of malignant myeloid cells in the lymph sinuses (Fig. 20) . In several mice with diffuse myelosis there was a diffuse infiltration about the thoracic vertebrae and costovertebral angle, involving the muscle tissue and often causing weakness of hind legs.
DISCUSSION
The experiments described here bring experimental proof for the assumption that myeloid leukemia of a mammal (mouse) is a neoplasm. The malignant cells of the strain described are basophile myelocytes and they produce the systemic disease with leukemia but with no tumor formation in some animals, and multiple myeloma alone in others.
The strain described has well defined characteristics that have remained constant throughout this study. These are: morphological peculiarities of the malignant myelocytes, relatively chronic course of illness, ability to form tumors in the injected subcutaneous tissue with little tendency to invade the circulating blood. It is not probable that all myeloid leukemias of mice that will prove transmissible will behave in the same way. Experience with five strains of lymphoid leukemia (5) points to the contrary, since careful analysis of these transmissible strains has revealed distinguishing characters in each. More recent experience with lymphoid leukemia of mice has confirmed these observations. Several strains have been observed that did not possess the ability to form tumors in the subcutaneous tissue; one strain was associated with icterus and erythroblastosis.
An explanation of the difficulty of transmitting myeloid neoplasms is desirable since procedures such as those successfully applied to spontaneous myelosis Ar 117 have failed in numerous instances of similar disease.
Two factors are significant in determining whether diffuse myelosis or myeloma is produced; namely, the route of entry and the resistance of the host. A third factor, the inoculating dose, has been discussed in the text. Spontaneous multiple myelOma may b,c either multicentric in origin, such as the bone sarcoma produced by irradiation (of. Martland (9)) or may be unicentric and develop after intravenous dissemination as in our resistant mice. Studies of lymphomatosis (of. 5) indicate that there is a fourth factor that is probably highly significant in determining the type of myelosis; namely, the character of the malignant myeloid cells. This factor can be revealed only by transmission experiments made with several strains of myelosis, under identical conditions. The experimental disease produced by the malignant cells may be acute and destroy the mouse within from 2 to 3 weeks, or it may be chronic, causing the frst manifestations of illness after about 2 months, progressing slowly, and causing the death of the animal from 4 to 5 months after inoculation. Variations in the route of entry, resistance of the host, and inoculating dose may account for these differences. Thus the classification of leukemias into acute and chronic forms is highly arbitrary and does not distinguish different types of diseases
(of. 5).
A single factor, e.g. resistance of the host, may delay the course of illness and modify its type. It has been shown that after intravenous inoculation with a large dose, irradiated mice (animals with low resistance) die within 2 to 3 weeks with systemic leukemic myelosis, whereas unirradiated mice of the same moderately resistant stock develop, instead of systemic myelosis, multiple myeloma. Evidently the resistant mice employed had the ability to destroy the malignant cells in the spleen and liver, but they were unable to cope with the malignant cells that lodged in some tissues favorable for their growth where they multiplied and produced tumors. The soil favorable to the best growth may differ with each malignant cell and may determine some of the characteristic features of the strain. For example, the malignant myelocytes of Strain Ar 117 grow well in areolar and muscle tissue; the malignant lymphocytes of our Strain Rg 10 favor the ovaries, and bilateral ovarian lymphosarcoma may be the only gross evidence of successful inoculation with this strain (of. 5).
Leukemias and tumors composed of either myeloid or lymphoid blood cells are similar malignant diseases, the manifestations of which depend on numerous factors, for example (a) character of the malignant cell, (b) route of entry (point of origin), (c) resistance of the host, (d) inoculating dose (i.e. number of cells that have undergone malignant transformation). The observation that with greatly decreased doses the course of the disease is only slightly lengthened is significant in relation to the effect of X-rays in leukemia. Irradiation of the entire body of leukemic mice with/(-rays and radium prolongs the life of the animals, probably because these rays destroy many malignant blood cells (10).
SUMMARY
A transmissible strain of myeloid leukemia of mice is described. It can be readily passed from diseased to healthy mice by the transfer of tissues that contain live cells; but inoculation fails when the latter are not present.
Inoculation is successful in almost every mouse whose resistance is lowered by X-rays. It is often successful in mice related to the animal in which the spontaneous leukemia took its origin, and occasionally successful in mice unrelated to it.
The systemic diffuse disease (myeloid leukemia) is produced only by intravenous inoculation with relatively large doses, whereas subcutaneous or intraperitoneal inoculation results in the formation of tumors composed of myelocytes with basophile granules, in other words malignant blood cells of the strain described.
Intravenous inoculation with small doses in susceptible mice, or similar inoculation with larger doses in somewhat resistant mice, results in the formation of tumors composed of myelocytes (multiple myeloma).
CONCLUSIONS
Experiments demonstrate that transmissible myeloid leukemia of mice is a neoplasm. The malignant immature granulocytes that produce the systemic disease may also produce tumors (multiple myeloma).
Some factors that determine the type of transmitted myelosis are (a) the resistance of the host, (b) the route of entry, (c) the character of the malignant cell, and, probably, (d) the inoculating dose. 
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Fro. 7. Diffuse mydosis (myeloid leukemia) produced by transfer of myeloid cells to an irradiated mouse. The spleen is greatly enlarged, the liver is moderately enlarged, and there are numerous small hemorrhagic infarcts in the lung. FIGS. 12 to 16. Myelocytes with basophile granules and one neutrophile polymorphonuclear leukocyte (Fig. 13) . Magnifications Figs. 12, 13 
